NCT06392009

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2024-07-10Est. Completion: 2026-06

Enrollment target: 30 participants

Locations

Queensland Children Hospital, South Brisbane, Australia
University Hospitals Leuven, Pediatric Neurology, Leuven, Belgium
Alberta Children's Hospital, Calgary, Canada
The Hospital for Sick Children (Sick Kids), Toronto, Canada
IRCCS Istituto Giannina Gaslini, Genoa, Liguria, Italy
AOU Meyer, Florence, Tuscany, Italy
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy
Universita Cattolica del Sacro Cuore - Policlinico Universitario "Agostino Gemelli", Roma, Italy
UMC Uthrecht - Wilhelmina Kinderziekenhuis, Utrecht, Netherlands
Uniwersyteckie Centrum Kliniczne, Gdansk, Poland
Centrum Medyczne Plejady, Krakow, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Poland
Instytut Pomnik - Centrum Zdrowia Dziecka, Warsaw, Poland
Hospital Universitario Vall D´Hebrón, Barcelona, Spain
Hospital Materno Infantil Sant Joan de Deu de Barcelona, Barcelona, Spain
Hospital Universitario Vithas La Milagrosa, Madrid, Spain
Hospital Ruber Internacional, Madrid, Spain

Renal Angiomyolipoma

The purpose of this prospective study is to assess the safety and efficacy of everolimus in Taiwanese patients with rena…

Taichung, TaiwanEst. completion Oct 10, 2026

Focal Seizures

Cannabidiol oral solution (CBD-OS) is approved in the US for the treatment of seizures associated with Lennox-Gastaut sy…

Phoenix, United StatesEst. completion Nov 29, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.